We examine whether the joint clinical assessment will expedite patient access and influence value pe...
Read moreThe Spanish Ministry of Health's Draft Royal Decree on HTA reshapes assessments, aligning with EU-H...
Read moreThe collaboration is aimed at enhancing HTA reports, facilitating resource and knowledge sharing and...
Read moreWe summarise the key discussions from HTAi 2024, with a focus on sustainability, networks and innova...
Read moreWe discuss the updates on EU HTA from the June meeting of the Member State Coordination Group on Hea...
Read moreLearn how to navigate the upcoming EU HTA regulation and optimise market access strategies for oncol...
Read moreRemap Consulting guides participants through the intricacies of incorporating EU HTA considerations ...
Read moreAIFA's restructuring in Italy aims to streamline drug approval, replacing committees and introducing...
Read moreBack in January this year, we summarised the key trends our market access experts believed would dom...
Read moreWe summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H...
Read more